Tolvaptan Open-Label Pilot Efficacy, Tolerability and Safety Study in ADPKD

Update Il y a 4 ans
Reference: NCT00413777

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study's purpose is to evaluate the long-term safety of open-label tolvaptan regimens to determine the maximally-tolerated dose and acquire pilot efficacy data in patients with ADPKD.


Inclusion criteria

  • Polycystic kidney, autosomal dominant

Links